The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

Evrysdi maintains its strong global position ... channel filling we saw immediately after the launch of pre-filled syringe. So we saw a little bit of a spend down in Q4, but we are seeing a ...

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for 2025. Sales in 2024 totaled $68.7 billion, which beat the Zacks Consensus ...

Over the past 30 years, peripheral vascular embolization has significantly expanded, now encompassing a wide range of applications, including the treatment of vascular malformations, uterine artery ...

Locals near a needle exchange site in a Bronx park are cheering a councilman’s proposal to require city health workers to collect hundreds of discarded syringes littering the ground. Oswald ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab-irmb) has been approved by the US Food and Drug Administration (FDA) for monthly maintenance dosing. The anti-amyloid drug was ...

Pfizer has shared positive results from a late-stage study of its Braftovi (encorafenib) combination in BRAF V600E-mutant metastatic colorectal cancer (mCRC). The ongoing phase 3 BREAKWATER trial has ...